NeoSypher Limited - Period Ending 2020-03-31

NeoSypher Limited - Period Ending 2020-03-31


NeoSypher Limited 09544979 false 2019-04-01 2020-03-31 2020-03-31 The principal activity of the company is the provision of data analysis services to the pharmaceutical industry Digita Accounts Production Advanced 6.26.9041.0 true 09544979 2019-04-01 2020-03-31 09544979 2020-03-31 09544979 bus:OrdinaryShareClass1 2020-03-31 09544979 bus:OrdinaryShareClass2 2020-03-31 09544979 bus:OrdinaryShareClass3 2020-03-31 09544979 bus:OrdinaryShareClass4 2020-03-31 09544979 bus:OrdinaryShareClass5 2020-03-31 09544979 bus:PreferenceShareClass1 bus:CumulativeNon-redeemableShares 2020-03-31 09544979 core:RetainedEarningsAccumulatedLosses 2020-03-31 09544979 core:ShareCapital 2020-03-31 09544979 core:CurrentFinancialInstruments 2020-03-31 09544979 core:CurrentFinancialInstruments core:WithinOneYear 2020-03-31 09544979 core:FurnitureFittingsToolsEquipment 2020-03-31 09544979 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity 2020-03-31 09544979 bus:SmallEntities 2019-04-01 2020-03-31 09544979 bus:AuditExemptWithAccountantsReport 2019-04-01 2020-03-31 09544979 bus:FullAccounts 2019-04-01 2020-03-31 09544979 bus:SmallCompaniesRegimeForAccounts 2019-04-01 2020-03-31 09544979 bus:RegisteredOffice 2019-04-01 2020-03-31 09544979 bus:Director1 2019-04-01 2020-03-31 09544979 bus:Director2 2019-04-01 2020-03-31 09544979 bus:Director3 2019-04-01 2020-03-31 09544979 bus:Director4 2019-04-01 2020-03-31 09544979 bus:Director5 2019-04-01 2020-03-31 09544979 bus:OrdinaryShareClass1 2019-04-01 2020-03-31 09544979 bus:OrdinaryShareClass2 2019-04-01 2020-03-31 09544979 bus:OrdinaryShareClass3 2019-04-01 2020-03-31 09544979 bus:OrdinaryShareClass4 2019-04-01 2020-03-31 09544979 bus:OrdinaryShareClass5 2019-04-01 2020-03-31 09544979 bus:PreferenceShareClass1 bus:CumulativeNon-redeemableShares 2019-04-01 2020-03-31 09544979 bus:PrivateLimitedCompanyLtd 2019-04-01 2020-03-31 09544979 core:RetainedEarningsAccumulatedLosses 2019-04-01 2020-03-31 09544979 core:ShareCapital 2019-04-01 2020-03-31 09544979 core:ComputerEquipment 2019-04-01 2020-03-31 09544979 core:FurnitureFittingsToolsEquipment 2019-04-01 2020-03-31 09544979 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity 2019-04-01 2020-03-31 09544979 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity core:RenderingOrReceivingServices 2019-04-01 2020-03-31 09544979 1 2019-04-01 2020-03-31 09544979 countries:England 2019-04-01 2020-03-31 09544979 2019-03-31 09544979 core:RetainedEarningsAccumulatedLosses 2019-03-31 09544979 core:ShareCapital 2019-03-31 09544979 core:FurnitureFittingsToolsEquipment 2019-03-31 09544979 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity 2019-03-31 09544979 2018-04-01 2019-03-31 09544979 2019-03-31 09544979 bus:OrdinaryShareClass1 2019-03-31 09544979 bus:OrdinaryShareClass2 2019-03-31 09544979 bus:OrdinaryShareClass3 2019-03-31 09544979 bus:OrdinaryShareClass4 2019-03-31 09544979 bus:OrdinaryShareClass5 2019-03-31 09544979 bus:PreferenceShareClass1 bus:CumulativeNon-redeemableShares 2019-03-31 09544979 core:RetainedEarningsAccumulatedLosses 2019-03-31 09544979 core:ShareCapital 2019-03-31 09544979 core:CurrentFinancialInstruments 2019-03-31 09544979 core:CurrentFinancialInstruments core:WithinOneYear 2019-03-31 09544979 core:FurnitureFittingsToolsEquipment 2019-03-31 09544979 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity 2019-03-31 09544979 core:RetainedEarningsAccumulatedLosses 2018-04-01 2019-03-31 09544979 core:ShareCapital 2018-04-01 2019-03-31 09544979 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity 2018-04-01 2019-03-31 09544979 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity core:RenderingOrReceivingServices 2018-04-01 2019-03-31 09544979 2018-03-31 09544979 core:RetainedEarningsAccumulatedLosses 2018-03-31 09544979 core:ShareCapital 2018-03-31 09544979 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity 2018-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09544979

NeoSypher Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2020

 

NeoSypher Limited

Contents

Company Information

1

Directors' Report

2

Balance Sheet

3

Statement of Changes in Equity

4

Notes to the Unaudited Financial Statements

5 to 11

 

NeoSypher Limited

Company Information

Directors

Mr A J Davis

Mr A S Knights

Mr B Holdsworth

Mr M D Holdsworth

Mr A Giles

Registered office

8 St. Johns Business Park
Lutterworth
LE17 4HB

Accountants

Vanilla Accounting Limited
Chartered Accountants
Appleton House
25 Rectory Road
West Bridgford
Nottingham
Nottinghamshire
NG2 6BE

 

NeoSypher Limited

Directors' Report for the Year Ended 31 March 2020

The directors present their report and the financial statements for the year ended 31 March 2020.

Directors of the company

The directors who held office during the year were as follows:

Mr A J Davis

Mr A S Knights

Mr B Holdsworth

Mr M D Holdsworth

Mr A Giles

Principal activity

The principal activity of the company is the provision of data analysis services to the pharmaceutical industry

Important non adjusting events after the financial period

On the 3rd February 2021 the entire share capital of the business was purchased by NeoHealthHub Ltd to form part of the NeoHealthHub Group of companies. This event has no effect on the financial statements prepared to the 31st March 2020

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved by the Board on 8 March 2021 and signed on its behalf by:

.........................................
Mr A Giles
Director

 

NeoSypher Limited

(Registration number: 09544979)
Balance Sheet as at 31 March 2020

Note

2020
£

2019
£

Fixed assets

 

Tangible assets

4

8,219

9,255

Current assets

 

Debtors

5

280,873

417,228

Cash at bank and in hand

 

118,488

87,141

 

399,361

504,369

Creditors: Amounts falling due within one year

6

(135,525)

(245,090)

Net current assets

 

263,836

259,279

Total assets less current liabilities

 

272,055

268,534

Provisions for liabilities

(1,562)

-

Net assets

 

270,493

268,534

Capital and reserves

 

Called up share capital

7

1,843

1,843

Profit and loss account

268,650

266,691

Shareholders' funds

 

270,493

268,534

For the financial year ending 31 March 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 8 March 2021 and signed on its behalf by:
 

.........................................

Mr A Giles
Director

 

NeoSypher Limited

Statement of Changes in Equity for the Year Ended 31 March 2020

Share capital
£

Profit and loss account
£

Total
£

At 1 April 2019

1,843

266,691

268,534

Profit for the year

-

318,135

318,135

Total comprehensive income

-

318,135

318,135

Dividends

-

(316,176)

(316,176)

At 31 March 2020

1,843

268,650

270,493

Share capital
£

Profit and loss account
£

Total
£

At 1 April 2018

1,623

183,115

184,738

Profit for the year

-

487,572

487,572

Total comprehensive income

-

487,572

487,572

Dividends

-

(403,996)

(403,996)

New share capital subscribed

240

-

240

Other share capital movements

(20)

-

(20)

At 31 March 2019

1,843

266,691

268,534

 

NeoSypher Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
8 St. Johns Business Park
Lutterworth
LE17 4HB
England

These financial statements were authorised for issue by the Board on 8 March 2021.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

NeoSypher Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

3 years Straight Line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

 

NeoSypher Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 7 (2019 - 4).

 

NeoSypher Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2019

13,295

13,295

Additions

3,201

3,201

At 31 March 2020

16,496

16,496

Depreciation

At 1 April 2019

4,040

4,040

Charge for the year

4,237

4,237

At 31 March 2020

8,277

8,277

Carrying amount

At 31 March 2020

8,219

8,219

At 31 March 2019

9,255

9,255

5

Debtors

Note

2020
£

2019
£

Trade debtors

 

130,860

214,958

Amounts owed by group undertakings and undertakings in which the company has a participating interest

10

107,638

197,303

Prepayments

 

2,425

1,517

Other debtors

 

39,950

3,450

 

280,873

417,228

 

NeoSypher Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

6

Creditors

Creditors: amounts falling due within one year

Note

2020
£

2019
£

Due within one year

 

Loans and borrowings

8

-

30,000

Trade creditors

 

-

2,759

Amounts owed to group undertakings and undertakings in which the company has a participating interest

10

1,494

-

Taxation and social security

 

133,156

204,271

Accruals and deferred income

 

-

3,267

Other creditors

 

875

4,793

 

135,525

245,090

7

Share capital

Allotted, called up and fully paid shares

 

2020

2019

 

No.

£

No.

£

Ordinary 'A' shares of £1 each

100

100

100

100

Ordinary 'B' shares of £1 each

100

100

100

100

Ordinary 'C' shares of £1 each

100

100

100

100

Ordinary 'D' shares of £1 each

-

-

-

-

Ordinary 'E' shares of £1 each

-

-

-

-

Preference shares of £1 each

1,543

1,543

1,543

1,543

 

1,843

1,843

1,843

1,843

8

Loans and borrowings

2020
£

2019
£

Current loans and borrowings

Other borrowings

-

30,000

 

NeoSypher Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

9

Dividends

   

2020

 

2019

   

£

 

£

Interim dividend of £1,054 (2019 - £1,346) per ordinary share

 

316,176

 

403,996

         

10

Related party transactions

Directors' remuneration

The directors' remuneration for the year was as follows:

2020
£

2019
£

Remuneration

28,800

24,000

Summary of transactions with entities with joint control or significant interest

Transactions have taken place during the year with entities under the common controlk of the directors. These transactions are made up of intercompany loans, management fees and recharged expenditure.
 

Income and receivables from related parties

2020

Entities with joint control or significant influence
£

Receipt of services

77,037

Expenses recognised as bad debt

(67,956)

Amounts receivable from related party

22,927

2019

Entities with joint control or significant influence
£

Receipt of services

158,500

Amounts receivable from related party

117,600

 

NeoSypher Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

Expenditure with and payables to related parties

2020

Entities with joint control or significant influence
£

Rendering of services

66,959

2019

Entities with joint control or significant influence
£

Rendering of services

47,803

Loans to related parties

2020

Entities with joint control or significant influence
£

Total
£

At start of period

82,123

82,123

Advanced

4,834

4,834

At end of period

86,957

86,957

2019

Entities with joint control or significant influence
£

Total
£

At start of period

25,000

25,000

Advanced

54,060

54,060

Interest transactions

3,063

3,063

At end of period

82,123

82,123

11

Non adjusting events after the financial period

On the 3rd February 2021 the entire share capital of the business was purchased by NeoHealthHub Ltd to form part of the NeoHealthHub Group of companies. This event has no effect on the financial statements prepared to the 31st March 2020